Remove 2025 Remove Hospitals Remove Packaging
article thumbnail

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

Pharmacists can also provide diabetes management as an embedded member of clinic or hospital locations. July 15, 2025. Accessed July 21, 2025. Accessed July 21, 2025. Kirsty [package insert]. However, education is one of the most prudent roles of pharmacists in diabetes care. News release. Biocon Biologics.

FDA
article thumbnail

Reimagining hospital pharmacy through sustainability and disruptive health technology

Hospital Pharmacy Europe

Sustainability has become central to the mission of hospital pharmacists, who are uniquely positioned to minimise waste, reduce healthcares environmental footprint and enhance patient outcomes. As climate concerns intensify, hospital pharmacists increasingly recognise the significant impact of their decisions on both patients and the planet.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days.

article thumbnail

Hengrui Pharma and GSK link across key therapeutic areas

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HRS-9821 aligns with GSK’s goal to address a broad spectrum of COPD patients. Credit: OleksSH / Shutterstock.com.

article thumbnail

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

Robert Barrie August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. Known under the brand name Blujepa, the drug was approved in the US to treat urinary tract infections in March 2025.

article thumbnail

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.

FDA
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.